Search Results - "Franke, Knut H."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma by STEINHOFF, Christine, FRANKE, Knut H, GOLKA, Klaus, THIER, Ricarda, RÖMER, Hermann C, RÖTZEL, Claudia, ACKERMANN, Rolf, SCHULZ, Wolfgang A

    Published in Archives of toxicology (01-11-2000)
    “…Genotype distributions for GSTP1, GSTM1, and GSTT1 were determined in 91 patients with prostatic carcinoma and 135 patients with bladder carcinoma and compared…”
    Get full text
    Journal Article
  2. 2

    DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder by FLORL, Andrea R, FRANKE, Knut H, NIEDERACHER, Dieter, GERHARZ, Claus-Dieter, SEIFERT, Hans-Helge, SCHULZ, Wolfgang A

    Published in Laboratory investigation (01-10-2000)
    “…Alterations of the CDKN2A locus on chromosome 9p21 encoding the p16INK4A cell cycle regulator and the p14ARF1 p53 activator proteins are frequently found in…”
    Get full text
    Journal Article
  3. 3

    Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma by Kimura, Fumihiro, Franke, Knut H., Steinhoff, Christine, Golka, Klaus, Roemer, Hermann C., Anastasiadis, Aristoteles G., Schulz, Wolfgang A.

    Published in The Prostate (01-11-2000)
    “…BACKGROUND Alterations of DNA methylation are very frequent in prostatic carcinoma. A possible cause underlying altered DNA methylation could be an…”
    Get full text
    Journal Article
  4. 4

    Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade by Schmidt, Bettina, Anastasiadis, Aristotelis G, Seifert, Hans-Helge, Franke, Knut H, Oya, Mototsugu, Ackermann, Rolf

    Published in Anticancer research (01-09-2003)
    “…The purpose of this study was to establish a quantitative standardized RT-PCR for the detection of Prostate Specific Membrane Antigen (PSMA)-expressing…”
    Get more information
    Journal Article
  5. 5

    Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma by Franke, K H, Miklosi, M, Goebell, P, Clasen, S, Steinhoff, C, Anastasiadis, A G, Gerharz, C, Schulz, W A

    Published in Urology (Ridgewood, N.J.) (01-10-2000)
    “…To evaluate the expression of p27(KIP1) and p21(CIP1) and the prognostic values of both markers in urothelial carcinoma. The expression of the cyclin-dependent…”
    Get full text
    Journal Article
  6. 6

    p27KIP1-expression in human renal cell cancers: implications for clinical outcome by Anastasiadis, Aristotelis G, Calvo-Sanchez, David, Franke, Knut H, Ebert, Thomas, Heydthausen, Manfred, Schulz, Wolfgang A, Burchardt, Martin, Gerharz, Claus-Dieter

    Published in Anticancer research (01-01-2003)
    “…p27Kip1 (p27) protein is an inhibitor of cyclin-dependent kinase complexes and prevents progression of cells from the G1- to the S-phase of the cell cycle…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Cyclin-dependent kinase inhibitor p27 KIP1 is expressed preferentially in early stages of urothelial carcinoma by Franke, Knut H, Miklosi, Mario, Goebell, Peter, Clasen, Sonja, Steinhoff, Christine, Anastasiadis, Aristoteles G, Gerharz, Claus-Dieter, Schulz, Wolfgang A

    Published in Urology (Ridgewood, N.J.) (2000)
    “…Objectives. To evaluate the expression of p27 KIP1 and p21 CIP1 and the prognostic values of both markers in urothelial carcinoma. The expression of the…”
    Get full text
    Journal Article